Loading...

Buy Full Version
"U.S. Thrombectomy Devices Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

U.S. Thrombectomy Devices Market by Technology (Mechanical Thrombectomy Devices, Aspiration Thrombectomy Devices, and Rheolytic Thrombectomy Devices), Type (Automated Thrombectomy Devices and Manual Thrombectomy Devices), Disease (Neurovascular Thrombectomy Devices, Peripheral Thrombectomy Devices, and Coronary Thrombectomy Devices), and Utility (Reusable Thrombectomy Devices and Disposable Thrombectomy Devices): Opportunity Analysis and Industry Forecast, 2018 - 2025

LI_195195
Pages: 119
Feb 2019 | 1597 Views
 
Author(s) : Sohail Shaikh & Onkar Sumant
Tables: 34
Charts: 48
 

U.S. Thrombectomy Devices Market Outlook - 2025

The U.S. thrombectomy devices market was valued at $501.9 million in 2017, and is expected to reach $750.4 million by 2025. This market is anticipated to grow at a CAGR of 5.1% during the forecast period. Thrombectomy devices are used to treat blood clots present in the arteries, veins, and capillaries. These devices are carefully designed to minimize damage to the vessel wall during the procedure, with minimum blood loss. They are available in different sizes and diameters, and depending on the affected area, the required catheter is chosen. These devices are used to treat acute myocardial infraction, peripheral arterial diseases, deep vein thrombosis, pulmonary embolism, and neurovascular thrombosis conditions.

Get more information on this report : Request Sample Pages

This is attributed by the increase in the incidence of chronic diseases due to the sedentary lifestyle and unhealthy living conditions and habits in the current generation. In addition, rise in geriatric population has led to increase in the incidence of cardiovascular diseases, which is expected to be one of the growth factors of the thrombectomy devices market. Furthermore, growth in demand for minimally invasive procedures and better healthcare infrastructure along with the increase in the competition has led to technological advancements and innovations. These factors are further anticipated to drive the thrombectomy devices market. However, lack of trained professionals and complicated use of these devices restrict the market growth. In addition, deep vein thrombosis and pulmonary embolism sometimes remain underdiagnosed and can lead to serious health conditions, which can only be avoided by escaping the sedentary lifestyle and creating awareness among all age groups.

The report covers the U.S. thrombectomy devices market analysis based on five categories, which include technology, type, disease, and utility. Based on the technology used, the U.S. thrombectomy devices market is categorized into mechanical thrombectomy devices, aspiration thrombectomy devices, and rheolytic thrombectomy devices. Based on type, the market is divided into automated thrombectomy devices and manual thrombectomy devices. On the basis of utility of devices, the market is classified into reusable thrombectomy devices and disposable thrombectomy devices. Furthermore, the U.S. thrombectomy devices market is segmented into three types of diseases, namely, peripheral thrombectomy devices, coronary thrombectomy devices, and neurovascular thrombectomy devices.

Get more information on this report : Request Sample Pages

The U.S. thrombectomy devices market size is analyzed by the technology vertical in the report. By technology, the mechanical U.S. thrombectomy devices market occupied the largest share in 2017, this trend is expected to continue throughout the forecast period as mechanical thrombectomy devices have replaced traditional manual aspiration thrombectomy devices due to better debulking of clot from large, proximal arteries. In addition, large vessel occlusions can be treated better by mechanical aspiration thrombectomy devices rather than chemical thrombolysis, which is usually futile.

Get more information on this report : Request Sample Pages

The U.S. thrombectomy devices market share is also analyzed through type of devices. By type, manual thrombectomy devices occupied the largest share in 2017. Manual devices save electricity and reduce procedural cost in treating removal of thrombus. The trending manual devices include Export Aspiration Catheter by Medtronic plc, which is used to remove large venous clot without vessel occlusion. Other manual thrombectomy devices include the Pronto offered by Vascular Solutions, Solitaire FR Revascularization Device manufactured by Medtronic plc and others.

Get more information on this report : Request Sample Pages

Furthermore, the U.S. thrombectomy devices market trends are also analyzed through diseases. By disease, the neurovascular thrombectomy devices are anticipated to occupy the largest share in 2025. Neurovascular thrombectomy devices are a widely preferred modality as they are more advantageous than intravenous (IV) recombinant tissue plasminogen activator in recanalization. Furthermore, they have high efficiency in treating large occlusions and they also decrease the risk of hemorrhage.
The growing competition and continuous technological advancements have led to acquisitions by major players in the U.S. thrombectomy devices market. For instance, in August 2017, Philips completed the acquisition of The Spectranetics Corporation, a U.S.-based global leader in vascular intervention and lead management solutions. Likewise, Penumbra Inc., executed the acquisition of a controlling interest in its joint venture, MVI Health Inc. After closing the transaction, Penumbra increased its ownership to 90% of the equity of MVI Health for $20 million in upfront cash consideration.

There have also been considerable product developments in the industry. For instance, U.S. FDA has cleared numerous thrombectomy devices recently. Penumbra Inc. received 510(k) clearance from the U.S. FDA to market its ACE64 aspiration thrombectomy system for the revascularization of large vessel occlusions in patients with acute ischemic stroke. Likewise, Medtronic plc's Neurovascular business unit received U.S. FDA clearance of the Riptide(TM) Aspiration System, this system is a part of the Acute Ischemic Stroke (AIS) product portfolio of the company. Furthermore, CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, received 510(k) clearance from the U.S. FDA for EMBOTRAP II Revascularization Device, a next generation stent retriever used to capture and remove life-threatening blood clots from the brain following an ischemic stroke.

The key players profiled in this report include Boston Scientific Corporation, Medtronic Plc., Teleflex Incorporated, Penumbra Inc., Koninklijke Philips N.V., AngioDynamics, Inc., Terumo Corporation, Johnson and Johnson, Stryker Corporation, and Capture Vascular, Inc. The other players considered in the value chain analysis (but not in the report) include Argon Medical Devices, Inc., Inari Medical, Inc., and others.

Key Benefits for U.S. Thrombectomy Devices Market:

  • The report provides an extensive analysis of the current U.S. thrombectomy devices market trends and future estimations of the market.
  • The U.S. thrombectomy devices market scenario is comprehensively analyzed with respect to the technology, type, utility, and disease.
  • The U.S. thrombectomy devices market growth estimations in this report are based on high-end analysis of the key developments for 20182025.
  • Recent developments, key manufacturers, and market shares of U.S. thrombectomy devices market are listed in this report to analyze the competitive scenario of the market.

U.S. Thrombectomy Devices Key Market Segments:

By Technology

  • Mechanical Thrombectomy Devices
  • Aspiration Thrombectomy Devices
  • Rheolytic Thrombectomy Devices

By Type

  • Automated Thrombectomy Devices
  • Manual Thrombectomy Devices

By Disease

  • Peripheral Thrombectomy Devices
  • Coronary Thrombectomy Devices
  • Neural Thrombectomy Devices

By Utility

  • Reusable Thrombectomy Devices
  • Disposable Thrombectomy Devices
 

CHAPTER 1:    INTRODUCTION

1.1.    Report description
1.2.    Key benefits for stakeholders
1.3.    Key market segments

1.3.1.    List of key players profiled in the report

1.4.    Research methodology

1.4.1.    Secondary research
1.4.2.    Primary research
1.4.3.    Analyst tools and models

CHAPTER 2:    EXECUTIVE SUMMARY

2.1.    Key findings of the study
2.2.    CXO perspective

CHAPTER 3:    MARKET OVERVIEW

3.1.    Market definition and scope
3.2.    Key findings

3.2.1.    Top winning strategies
3.2.2.    Top investment pockets

3.3.    Top player positioning, 2017
3.4.    Porter’s five forces analysis
3.5.    Market dynamics

3.5.1.    Drivers

3.5.1.1.    High prevalence of PDA, AMI, DVT, and PE
3.5.1.2.    Surge in demand for minimally invasive procedures
3.5.1.3.    Technological advancements & innovations

3.5.2.    Restraints

3.5.2.1.    High cost and complications associated with the use of thrombectomy devices
3.5.2.2.    Dearth of trained professionals & lack of awareness

3.5.3.    Opportunities

3.5.3.1.    Introduction of lasers and UV radiation as well as 3D imaging generation in thrombectomy devices
3.5.3.2.    Combination of decompressive surgery and thrombectomy

CHAPTER 4:    U.S. THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY

4.1.    Overview

4.1.1.    Market size and forecast

4.2.    Mechanical thrombectomy devices

4.2.1.    Key market trends, growth factors, and opportunities
4.2.2.    Market size and forecast

4.3.    Aspiration thrombectomy devices

4.3.1.    Key market trends, growth factors, and opportunities
4.3.2.    Market size and forecast

4.4.    Rheolytic thrombectomy devices

4.4.1.    Key market trends, growth factors, and opportunities
4.4.2.    Market size and forecast

CHAPTER 5:    U.S. THROMBECTOMY DEVICES MARKET, BY TYPE

5.1.    Overview

5.1.1.    Market size and forecast

5.2.    Automated thrombectomy devices

5.2.1.    Market size and forecast

5.3.    Manual thrombectomy devices

5.3.1.    Market size and forecast

CHAPTER 6:    U.S. THROMBECTOMY DEVICES MARKET, BY DISEASE

6.1.    Overview

6.1.1.    Market size and forecast

6.2.    Neurovascular thrombectomy devices

6.2.1.    Market size and forecast

6.3.    Peripheral thrombectomy devices

6.3.1.    Market size and forecast

6.4.    Coronary thrombectomy devices

6.4.1.    Market size and forecast

CHAPTER 7:    U.S. THROMBECTOMY DEVICES MARKET, BY UTILITY

7.1.    Overview

7.1.1.    Market size and forecast

7.2.    Reusable thrombectomy devices

7.2.1.    Market size and forecast

7.3.    Disposable thrombectomy devices

7.3.1.    Market size and forecast

CHAPTER 8:    COMPANY PROFILES

8.1.    BOSTON SCIENTIFIC CORPORATION

8.1.1.    Company overview
8.1.2.    Company snapshot
8.1.3.    Operating business segments
8.1.4.    Product Portfolio
8.1.5.    Business performance
8.1.6.    Key strategic moves and developments

8.2.    JOHNSON & JOHNSON

8.2.1.    Company overview
8.2.2.    Company snapshot
8.2.3.    Operating business segments
8.2.4.    Product Portfolio
8.2.5.    Business performance
8.2.6.    Key strategic moves and developments

8.3.    MEDTRONIC PLC

8.3.1.    Company overview
8.3.2.    Company snapshot
8.3.3.    Operating business segments
8.3.4.    Product portfolio
8.3.5.    Business performance
8.3.6.    Key strategic moves and developments

8.4.    Stryker Corporation

8.4.1.    Company overview
8.4.2.    Company snapshot
8.4.3.    Operating business segments
8.4.4.    Product portfolio
8.4.5.    Business performance
8.4.6.    Key strategic move and development

8.5.    Teleflex Incorporated

8.5.1.    Company overview
8.5.2.    Company snapshot
8.5.3.    Operating business segments
8.5.4.    Product portfolio
8.5.5.    Business performance
8.5.6.    Key strategic move and development

8.6.    TERUMO MEDICAL CORPORATION

8.6.1.    Company overview
8.6.2.    Company snapshot
8.6.3.    Operating business segments
8.6.4.    Product portfolio
8.6.5.    Business performance
8.6.6.    Key strategic move and development

8.7.    KONINKLIJKE PHILIPS N.V.

8.7.1.    Company overview
8.7.2.    Company snapshot
8.7.3.    Operating business segments
8.7.4.    Business performance
8.7.5.    Product portfolio
8.7.6.    Key strategic moves and developments

8.8.    Angiodynamics Inc.

8.8.1.    Company overview
8.8.2.    Company snapshot
8.8.3.    Operating business segments
8.8.4.    Product Portfolio
8.8.5.    Business performance

8.9.    Penumbra, Inc.

8.9.1.    Company overview
8.9.2.    Company snapshot
8.9.3.    Operating business segments
8.9.4.    Product Portfolio
8.9.5.    Business performance
8.9.6.    Key strategic moves and developments

8.10.    Capture Vascular, Inc.

8.10.1.    Company overview
8.10.2.    Company snapshot
8.10.3.    Operating business segments
8.10.4.    Product portfolio

LIST OF TABLES

TABLE 01.    U.S. THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY, 2017–2025 ($MILLION)
TABLE 02.    U.S. THROMBECTOMY DEVICES MARKET, BY TYPE, 2017–2025 ($MILLION)
TABLE 03.    U.S. THROMBECTOMY DEVICES MARKET, BY DISEASE, 2017–2025 ($MILLION)
TABLE 04.    U.S. THROMBECTOMY DEVICES MARKET, BY UTILITY, 2017–2025 ($MILLION)
TABLE 05.    BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 06.    BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 07.    BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 08.    J&J: COMPANY SNAPSHOT
TABLE 09.    J&J: OPERATING SEGMENTS
TABLE 10.    J&J: PRODUCT PORTFOLIO
TABLE 11.    MEDTRONIC: COMPANY SNAPSHOT
TABLE 12.    MEDTRONIC: OPERATING SEGMENTS
TABLE 13.    MEDTRONIC: PRODUCT PORTFOLIO
TABLE 14.    STRYKER: COMPANY SNAPSHOT
TABLE 15.    STRYKER: OPERATING SEGMENTS
TABLE 16.    STRYKER: PRODUCT PORTFOLIO
TABLE 17.    TELEFLEX: COMPANY SNAPSHOT
TABLE 18.    TELEFLEX: OPERATING SEGMENTS
TABLE 19.    TELEFLEX: PRODUCT PORTFOLIO
TABLE 20.    TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 21.    TERUMO MEDICAL CORPORATION: OPERATING SEGMENTS
TABLE 22.    TERUMO MEDICAL CORPORATION: PRODUCT PORTFOLIO
TABLE 23.    PHILIPS: COMPANY SNAPSHOT
TABLE 24.    PHILIPS: OPERATING SEGMENTS
TABLE 25.    PHILIPS: PRODUCT PORTFOLIO
TABLE 26.    ANGIODYNAMICS INC.: COMPANY SNAPSHOT
TABLE 27.    ANGIODYNAMICS INC: OPERATING SEGMENTS
TABLE 28.    ANGIODYNAMICS INC.: PRODUCT PORTFOLIO
TABLE 29.    PENUMBRA, INC.: COMPANY SNAPSHOT
TABLE 30.    PENUMBRA INC: OPERATING SEGMENTS
TABLE 31.    PENUMBRA, INC.: PRODUCT PORTFOLIO
TABLE 32.    CAPTURE VASCULAR, INC.: COMPANY SNAPSHOT
TABLE 33.    CAPTURE VASCULAR, INC.: OPERATING BUSINESS SEGMENTS
TABLE 34.    CAPTURE VASCULAR, INC: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.    U.S. THROMBECTOMY DEVICE MARKET SEGMENTATION
FIGURE 02.    TOP WINNING STRATEGIES, 2015–2018
FIGURE 03.    TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2015–2018
FIGURE 04.    DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 05.    TOP INVESTMENT POCKETS
FIGURE 06.    TOP PLAYER POSITIONING, 2017
FIGURE 07.    MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.    LOW BARGAINING POWER OF SUPPLIERS
FIGURE 09.    MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.    MODERATE THREAT OF SUBSTITUTION
FIGURE 11.    HIGH COMPETITIVE RIVALRY
FIGURE 12.    MARKET DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 13.    U.S. THROMBECTOMY DEVICES MARKET FOR MECHANICAL THROMBECTOMY DEVICES, 2017–2025 ($MILLION)
FIGURE 14.    U.S. THROMBECTOMY DEVICES MARKET FOR ASPIRATION THROMBECTOMY DEVICES, 2017–2025 ($MILLION)
FIGURE 15.    U.S. THROMBECTOMY DEVICES MARKET FOR ASPIRATION THROMBECTOMY DEVICES, 2017–2025 ($MILLION)
FIGURE 16.    U.S. THROMBECTOMY DEVICES MARKET FOR AUTOMATED DEVICES, 2017–2025 ($MILLION)
FIGURE 17.    U.S. THROMBECTOMY DEVICES MARKET FOR MANUAL THROMBECTOMY DEVICES, 2017–2025 ($MILLION)
FIGURE 18.    U.S. THROMBECTOMY DEVICES MARKET FOR NEUROVASCULAR THROMBECTOMY DEVICES, 2017–2025 ($MILLION)
FIGURE 19.    U.S. THROMBECTOMY DEVICES MARKET FOR PERIPHERAL THROMBECTOMY DEVICES, 2017–2025 ($MILLION)
FIGURE 20.    U.S. THROMBECTOMY DEVICES MARKET FOR CORONARY THROMBECTOMY DEVICES, 2017–2025 ($MILLION)
FIGURE 21.    U.S. THROMBECTOMY DEVICES MARKET FOR REUSABLE THROMBECTOMY DEVICES, 2017–2025 ($MILLION)
FIGURE 22.    U.S. THROMBECTOMY DEVICES MARKET FOR DISPOSABLE THROMBECTOMY DEVICES, 2017–2025 ($MILLION)
FIGURE 23.    BOSTON SCIENTIFIC: NET SALES, 2015–2017 ($MILLION)
FIGURE 24.    BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2017 (%)
FIGURE 25.    BOSTON SCIENTIFIC: NET SALES, BY REGION, 2017 (%)
FIGURE 26.    J&J: NET SALES, 2015–2017 ($MILLION)
FIGURE 27.    J&J: REVENUE SHARE, BY SEGMENT, 2017 (%)
FIGURE 28.    J&J: REVENUE SHARE, BY REGION, 2017 (%)
FIGURE 29.    MEDTRONIC: NET SALES, 2015–2017 ($MILLION)
FIGURE 30.    MEDTRONIC: NET SALES, BY SEGMENT, 2017 (%)
FIGURE 31.    MEDTRONIC: NET SALES, BY REGION, 2017 (%)
FIGURE 32.    STRYKER: NET SALES, 2015–2017 ($MILLION)
FIGURE 33.    STRYKER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 34.    STRYKER: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 35.    TELEFLEX: NET SALES, 2015–2017 ($MILLION)
FIGURE 36.    TELEFLEX: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 37.    TERUMO MEDICAL CORPORATION: NET SALES, 2015–2017 ($MILLION)
FIGURE 38.    TERUMO MEDICAL CORPORATION: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 39.    TERUMO MEDICAL CORPORATION: REVENUE SHARE BY REGION, 2016 (%)
FIGURE 40.    PHILIPS: NET SALES, 2015–2017 ($MILLION)
FIGURE 41.    PHILIPS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 42.    PHILIPS: REVENUE SHARE BY REGION, 2017(%)
FIGURE 43.    ANGIODYNAMICS INC: REVENUE, 2016–2018 ($MILLION)
FIGURE 44.    ANGIODYNAMICS INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 45.    ANGIODYNAMICS INC.: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 46.    PENUMBRA, INC.: REVENUE, 2016–2018 ($MILLION)
FIGURE 47.    PENUMBRA, INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 48.    PENUMBRA, INC.: REVENUE SHARE BY REGION, 2017 (%)

 
 

The utilization of thrombectomy devices is expected to witness a significant rise with increase in application in treating neurovascular, peripheral, and coronary disorders. The thrombectomy devices market has piqued the interest of healthcare providers, as they can be used to treat clots efficiently. Devices such as mechanical, rheolytic, and aspiration thrombectomy products are used to treat peripheral, coronary, and neural clot-related diseases. Moreover, a remarkable increase in the usage of thrombectomy devices for the management of chronic disease patients has been observed since the past few years.

Some of the major factors that are expected to drive the market growth include rise in geriatric population, high demand for minimally invasive procedures & technological advancements, and innovations by key players. Furthermore, as per the CXOs, increase in incidence of cardiovascular diseases and need for better healthcare infrastructure fuel the growth of the market. However, lack of trained professionals, low awareness about thrombectomy devices, and complicated use of thrombectomy devices are the major factors that restrain the market growth.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Download Sample

Request Customization

Download Sample

OR

Purchase Full Report of
U.S. Thrombectomy Devices Market

  • Data Pack
  • $2,038
  • Restricted to one authorized user
  • One print only
  • Available in Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $2,850
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $3,423
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $4,774
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 
image image image image image image image image image image image image image image image image image image image
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
report-img

Published in May 2018

Acne Medication Market

Download Sample
report-img

Published in Sep 2016

CFRP Market

Download Sample
report-img

Published in Feb 2015

Mobile Security Market

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 
Download Sample